Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 100 of 17607 > >>
EC Number
Disease
PubMed ID
Title of Publication
Category
Confidence Level
Abortion, Septic
Umbilical cord 'pseudo-vasculitis' following second trimester fetal death: a clinicopathological and immunohistochemical study of 13 cases.
diagnostic usage
2
Abortion, Septic
Umbilical cord 'pseudo-vasculitis' following second trimester fetal death: a clinicopathological and immunohistochemical study of 13 cases.
ongoing research
2
Abortion, Septic
Umbilical cord 'pseudo-vasculitis' following second trimester fetal death: a clinicopathological and immunohistochemical study of 13 cases.
unassigned
0
Abortion, Spontaneous
[Human placental myeloperoxidase in miscarriage]
ongoing research
4
Abortion, Spontaneous
[Human placental myeloperoxidase in miscarriage]
unassigned
0
Abscess
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
causal interaction
4
Abscess
Partial characterization of a bactericidal system in staphylococcal abscesses.
diagnostic usage
1
Abscess
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
diagnostic usage
3
Abscess
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
therapeutic application
1
Abscess
Partial characterization of a bactericidal system in staphylococcal abscesses.
ongoing research
2
Abscess
Partial characterization of a bactericidal system in staphylococcal abscesses.
unassigned
0
Abscess
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
unassigned
0
Acatalasia
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
diagnostic usage
2
Acatalasia
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
therapeutic application
2
Acatalasia
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
ongoing research
1
Acatalasia
Catalase deficiency in myeloperoxidase deficient polymorphonuclear leucocytes from chicken.
unassigned
0
Acidosis
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition.
causal interaction
3
Acidosis
Acidosis stimulates nitric oxide production and lung damage in rats.
causal interaction
4
Acidosis
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition.
diagnostic usage
1
Acidosis
Acidosis stimulates nitric oxide production and lung damage in rats.
diagnostic usage
4
Acidosis
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition.
therapeutic application
1
Acidosis
Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release.
therapeutic application
1
Acidosis
Acidosis stimulates nitric oxide production and lung damage in rats.
therapeutic application
1
Acidosis
Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release.
ongoing research
1
Acidosis
The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
unassigned
0
Acidosis
Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release.
unassigned
0
Acidosis
Extracellular acidification induces human neutrophil activation.
unassigned
0
Acidosis
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition.
unassigned
0
Acidosis
Acidosis stimulates nitric oxide production and lung damage in rats.
unassigned
0
Acidosis, Lactic
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on haemodynamics or regional microvascular flow.
causal interaction
4
Acidosis, Lactic
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on haemodynamics or regional microvascular flow.
unassigned
0
Acne Vulgaris
Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
causal interaction
2
Acne Vulgaris
Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
ongoing research
3
Acne Vulgaris
Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
unassigned
0
Acquired Immunodeficiency Syndrome
Disseminated tubuloreticular inclusions in acquired immunodeficiency syndrome (AIDS).
diagnostic usage
4
Acquired Immunodeficiency Syndrome
Disseminated tubuloreticular inclusions in acquired immunodeficiency syndrome (AIDS).
ongoing research
4
Acquired Immunodeficiency Syndrome
Disseminated tubuloreticular inclusions in acquired immunodeficiency syndrome (AIDS).
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
causal interaction
1
Acute Coronary Syndrome
[Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]
causal interaction
4
Acute Coronary Syndrome
[Myeloperoxidase in the plasma of patients with acute coronary syndrome]
causal interaction
4
Acute Coronary Syndrome
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
causal interaction
4
Acute Coronary Syndrome
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
causal interaction
4
Acute Coronary Syndrome
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
causal interaction
4
Acute Coronary Syndrome
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
causal interaction
2
Acute Coronary Syndrome
Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes.
causal interaction
4
Acute Coronary Syndrome
A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.
causal interaction
1
Acute Coronary Syndrome
Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.
causal interaction
4
Acute Coronary Syndrome
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
causal interaction
4
Acute Coronary Syndrome
Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
causal interaction
4
Acute Coronary Syndrome
[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification]
causal interaction
1
Acute Coronary Syndrome
Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
causal interaction
4
Acute Coronary Syndrome
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
causal interaction
4
Acute Coronary Syndrome
Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
causal interaction
4
Acute Coronary Syndrome
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
causal interaction
4
Acute Coronary Syndrome
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
causal interaction
4
Acute Coronary Syndrome
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
causal interaction
4
Acute Coronary Syndrome
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
causal interaction
4
Acute Coronary Syndrome
Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
causal interaction
4
Acute Coronary Syndrome
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
causal interaction
1
Acute Coronary Syndrome
Long-term Prognostic Value of Myeloperoxidase on Acute Coronary Syndrome-A Meta-analysis.
causal interaction
4
Acute Coronary Syndrome
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
causal interaction
2
Acute Coronary Syndrome
Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
causal interaction
4
Acute Coronary Syndrome
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
causal interaction
2
Acute Coronary Syndrome
Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia.
causal interaction
1
Acute Coronary Syndrome
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
causal interaction
3
Acute Coronary Syndrome
Novel biomarkers for cardiovascular risk prediction.
causal interaction
3
Acute Coronary Syndrome
Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
causal interaction
4
Acute Coronary Syndrome
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
causal interaction
1
Acute Coronary Syndrome
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
diagnostic usage
4
Acute Coronary Syndrome
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
[Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]
diagnostic usage
4
Acute Coronary Syndrome
[Myeloperoxidase in the plasma of patients with acute coronary syndrome]
diagnostic usage
4
Acute Coronary Syndrome
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.
diagnostic usage
4
Acute Coronary Syndrome
[Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
diagnostic usage
4
Acute Coronary Syndrome
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
diagnostic usage
4
Acute Coronary Syndrome
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
diagnostic usage
3
Acute Coronary Syndrome
Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
diagnostic usage
3
Acute Coronary Syndrome
Serial Analyses of C-Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome.
diagnostic usage
2
Acute Coronary Syndrome
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
diagnostic usage
4
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase in the acute coronary syndrome: Equal concentrations at any time of day?
diagnostic usage
1
Acute Coronary Syndrome
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
diagnostic usage
3
Acute Coronary Syndrome
Letter by schindhelm regarding article, "high levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
diagnostic usage
1
Acute Coronary Syndrome
Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
diagnostic usage
1
Acute Coronary Syndrome
Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes.
diagnostic usage
2
Acute Coronary Syndrome
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
diagnostic usage
3
Acute Coronary Syndrome
Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels.
diagnostic usage
4
Acute Coronary Syndrome
A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
diagnostic usage
3
Acute Coronary Syndrome
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
diagnostic usage
3
Acute Coronary Syndrome
[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification]
diagnostic usage
3
Acute Coronary Syndrome
Multimarker panel to rule out acute coronary syndromes in low-risk patients.
diagnostic usage
4
Acute Coronary Syndrome
Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
diagnostic usage
4
Acute Coronary Syndrome
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
diagnostic usage
4
Acute Coronary Syndrome
Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
diagnostic usage
1
Acute Coronary Syndrome
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
diagnostic usage
4
Acute Coronary Syndrome
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
diagnostic usage
4
Acute Coronary Syndrome
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
diagnostic usage
4
Acute Coronary Syndrome
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
diagnostic usage
4
Acute Coronary Syndrome
Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
diagnostic usage
3
Acute Coronary Syndrome
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
diagnostic usage
3
Acute Coronary Syndrome
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
diagnostic usage
4
Acute Coronary Syndrome
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
diagnostic usage
3
Acute Coronary Syndrome
[Metabolic activity of neutrocytes and possible ways of its correction in patients with an acute coronal syndrome].
diagnostic usage
3
Acute Coronary Syndrome
Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
diagnostic usage
4
Acute Coronary Syndrome
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
diagnostic usage
3
Acute Coronary Syndrome
Identifying patients for early discharge: Performance of decision rules among patients with acute chest pain.
diagnostic usage
4
Acute Coronary Syndrome
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
diagnostic usage
4
Acute Coronary Syndrome
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
diagnostic usage
2
Acute Coronary Syndrome
Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia.
diagnostic usage
4
Acute Coronary Syndrome
The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
diagnostic usage
4
Acute Coronary Syndrome
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
diagnostic usage
3
Acute Coronary Syndrome
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
diagnostic usage
1
Acute Coronary Syndrome
Novel biomarkers for cardiovascular risk prediction.
diagnostic usage
3
Acute Coronary Syndrome
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
diagnostic usage
4
Acute Coronary Syndrome
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
diagnostic usage
4
Acute Coronary Syndrome
Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
diagnostic usage
4
Acute Coronary Syndrome
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
diagnostic usage
4
Acute Coronary Syndrome
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
therapeutic application
1
Acute Coronary Syndrome
[Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]
therapeutic application
2
Acute Coronary Syndrome
[Myeloperoxidase in the plasma of patients with acute coronary syndrome]
therapeutic application
1
Acute Coronary Syndrome
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
therapeutic application
2
Acute Coronary Syndrome
Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.
therapeutic application
1
Acute Coronary Syndrome
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
therapeutic application
1
Acute Coronary Syndrome
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
therapeutic application
1
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
therapeutic application
2
Acute Coronary Syndrome
Response: myeloperoxidase as a biomarker in acute coronary syndrome: a trap or a treasure.
therapeutic application
3
Acute Coronary Syndrome
Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
therapeutic application
1
Acute Coronary Syndrome
Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
therapeutic application
2
Acute Coronary Syndrome
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
therapeutic application
1
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
therapeutic application
1
Acute Coronary Syndrome
Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels.
therapeutic application
1
Acute Coronary Syndrome
A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.
therapeutic application
1
Acute Coronary Syndrome
Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.
therapeutic application
2
Acute Coronary Syndrome
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
therapeutic application
1
Acute Coronary Syndrome
Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
therapeutic application
1
Acute Coronary Syndrome
Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
therapeutic application
2
Acute Coronary Syndrome
Multimarker panel to rule out acute coronary syndromes in low-risk patients.
therapeutic application
1
Acute Coronary Syndrome
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
therapeutic application
1
Acute Coronary Syndrome
Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
therapeutic application
1
Acute Coronary Syndrome
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
therapeutic application
1
Acute Coronary Syndrome
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
therapeutic application
1
Acute Coronary Syndrome
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
therapeutic application
2
Acute Coronary Syndrome
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
therapeutic application
2
Acute Coronary Syndrome
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
therapeutic application
2
Acute Coronary Syndrome
Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia.
therapeutic application
3
Acute Coronary Syndrome
Amperometric myeloperoxidase immunoassay based on the use of CuPdPt nanowire networks.
therapeutic application
1
Acute Coronary Syndrome
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
therapeutic application
1
Acute Coronary Syndrome
Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
therapeutic application
2
Acute Coronary Syndrome
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.
ongoing research
3
Acute Coronary Syndrome
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
ongoing research
2
Acute Coronary Syndrome
[Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]
ongoing research
3
Acute Coronary Syndrome
[Myeloperoxidase in the plasma of patients with acute coronary syndrome]
ongoing research
4
Acute Coronary Syndrome
[Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]
ongoing research
4
Acute Coronary Syndrome
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
ongoing research
2
Acute Coronary Syndrome
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
ongoing research
1
Acute Coronary Syndrome
C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.
ongoing research
3
Acute Coronary Syndrome
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
ongoing research
1
Acute Coronary Syndrome
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
ongoing research
1
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
ongoing research
1
Acute Coronary Syndrome
A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome.
ongoing research
1
Acute Coronary Syndrome
Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.
ongoing research
4
Acute Coronary Syndrome
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
ongoing research
3
Acute Coronary Syndrome
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome.
ongoing research
3
Acute Coronary Syndrome
Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
ongoing research
4
Acute Coronary Syndrome
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
ongoing research
2
Acute Coronary Syndrome
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
ongoing research
2
Acute Coronary Syndrome
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
ongoing research
1
Acute Coronary Syndrome
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
ongoing research
1
Acute Coronary Syndrome
[Metabolic activity of neutrocytes and possible ways of its correction in patients with an acute coronal syndrome].
ongoing research
4
Acute Coronary Syndrome
Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
ongoing research
2
Acute Coronary Syndrome
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
ongoing research
2
Acute Coronary Syndrome
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
ongoing research
1
Acute Coronary Syndrome
The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
ongoing research
4
Acute Coronary Syndrome
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
ongoing research
3
Acute Coronary Syndrome
Novel biomarkers for cardiovascular risk prediction.
ongoing research
2
Acute Coronary Syndrome
Amperometric myeloperoxidase immunoassay based on the use of CuPdPt nanowire networks.
ongoing research
1
Acute Coronary Syndrome
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
ongoing research
4
Acute Coronary Syndrome
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
ongoing research
3
Acute Coronary Syndrome
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
ongoing research
1
Acute Coronary Syndrome
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
[Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]
unassigned
0
Acute Coronary Syndrome
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
unassigned
0
Acute Coronary Syndrome
C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Serial Analyses of C-Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome.
unassigned
0
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase in the acute coronary syndrome: Equal concentrations at any time of day?
unassigned
0
Acute Coronary Syndrome
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Letter by schindhelm regarding article, "high levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
unassigned
0
Acute Coronary Syndrome
Response: myeloperoxidase as a biomarker in acute coronary syndrome: a trap or a treasure.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
unassigned
0
Acute Coronary Syndrome
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
unassigned
0
Acute Coronary Syndrome
Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels.
unassigned
0
Acute Coronary Syndrome
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
unassigned
0
Acute Coronary Syndrome
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome.
unassigned
0
Acute Coronary Syndrome
A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
unassigned
0
Acute Coronary Syndrome
Multimarker panel to rule out acute coronary syndromes in low-risk patients.
unassigned
0
Acute Coronary Syndrome
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
unassigned
0
Acute Coronary Syndrome
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
unassigned
0
Acute Coronary Syndrome
[Metabolic activity of neutrocytes and possible ways of its correction in patients with an acute coronal syndrome].
unassigned
0
Acute Coronary Syndrome
Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
unassigned
0
Acute Coronary Syndrome
Identifying patients for early discharge: Performance of decision rules among patients with acute chest pain.
unassigned
0
Acute Coronary Syndrome
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
unassigned
0
Acute Coronary Syndrome
The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
unassigned
0
Acute Coronary Syndrome
Amperometric myeloperoxidase immunoassay based on the use of CuPdPt nanowire networks.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
unassigned
0
Acute Coronary Syndrome
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
unassigned
0
Acute Coronary Syndrome
Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
unassigned
0
Acute Coronary Syndrome
Long-term Prognostic Value of Myeloperoxidase on Acute Coronary Syndrome-A Meta-analysis.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification]
unassigned
0
Acute Coronary Syndrome
Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
unassigned
0
Acute Coronary Syndrome
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
unassigned
0
Acute Coronary Syndrome
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
unassigned
0
Acute Coronary Syndrome
Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
unassigned
0
Acute Coronary Syndrome
Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
unassigned
0
Acute Coronary Syndrome
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
unassigned
0
Acute Coronary Syndrome
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
unassigned
0
Acute Coronary Syndrome
Novel biomarkers for cardiovascular risk prediction.
unassigned
0
Acute Coronary Syndrome
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
unassigned
0
Acute Coronary Syndrome
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
unassigned
0
Acute Coronary Syndrome
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
unassigned
0
Acute Coronary Syndrome
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
unassigned
0
Acute Coronary Syndrome
Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
unassigned
0
Acute Coronary Syndrome
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
unassigned
0
Acute Coronary Syndrome
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
unassigned
0
Acute Coronary Syndrome
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
unassigned
0
Acute Coronary Syndrome
Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia.
unassigned
0
Acute Coronary Syndrome
Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
unassigned
0
Acute Kidney Injury
Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.
causal interaction
1
Acute Kidney Injury
Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
causal interaction
4
Acute Kidney Injury
Inhibition of glycogen synthase kinase-3? attenuates acute kidney injury in sodium taurocholate?induced severe acute pancreatitis in rats.
causal interaction
4
Acute Kidney Injury
Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.
diagnostic usage
4
Acute Kidney Injury
The mechanism of myocardium and pancreas injury in rabbits with acute renal failure might be related to myeloperoxidase and membrane pump activities.
diagnostic usage
2
Acute Kidney Injury
Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
diagnostic usage
4
Acute Kidney Injury
Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomas.
diagnostic usage
4
Acute Kidney Injury
Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
diagnostic usage
1
Acute Kidney Injury
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
diagnostic usage
1
Acute Kidney Injury
Inhibition of glycogen synthase kinase-3? attenuates acute kidney injury in sodium taurocholate?induced severe acute pancreatitis in rats.
diagnostic usage
4
Acute Kidney Injury
Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
therapeutic application
3
Acute Kidney Injury
Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.
therapeutic application
3
Acute Kidney Injury
Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
therapeutic application
1
Acute Kidney Injury
Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
therapeutic application
1
Acute Kidney Injury
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
ongoing research
1
Acute Kidney Injury
Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.
ongoing research
4
Acute Kidney Injury
Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats.
ongoing research
2
Acute Kidney Injury
Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
ongoing research
1
Acute Kidney Injury
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
ongoing research
1
Acute Kidney Injury
Inhibition of glycogen synthase kinase-3? attenuates acute kidney injury in sodium taurocholate?induced severe acute pancreatitis in rats.
ongoing research
4
Acute Kidney Injury
The mechanism of myocardium and pancreas injury in rabbits with acute renal failure might be related to myeloperoxidase and membrane pump activities.
unassigned
0
Acute Kidney Injury
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
unassigned
0
Acute Kidney Injury
Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
unassigned
0
Acute Kidney Injury
Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.
unassigned
0
Acute Kidney Injury
Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomas.
unassigned
0
Acute Kidney Injury
Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
unassigned
0
Acute Kidney Injury
Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats.
unassigned
0
Acute Kidney Injury
Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
unassigned
0
Acute Kidney Injury
Churg-strauss syndrome presenting with acute renal insufficiency accompanied by eosinophilic tubulointerstitial nephritis.
unassigned
0
Acute Kidney Injury
Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.
unassigned
0
Acute Kidney Injury
Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.
unassigned
0
Acute Kidney Injury
Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption.
unassigned
0
Acute Kidney Injury
Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
unassigned
0
Acute Kidney Injury
Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.
unassigned
0
Acute Kidney Injury
Inhibition of glycogen synthase kinase-3? attenuates acute kidney injury in sodium taurocholate?induced severe acute pancreatitis in rats.
unassigned
0
Acute Lung Injury
The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate.
causal interaction
1
Acute Lung Injury
Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.
causal interaction
1
Acute Lung Injury
Myeloperoxidase-induced inactivation of alpha 1-antiprotease in hamsters.
causal interaction
1
Acute Lung Injury
Clinical significance of measuring myeloperoxidase, thiobarbituric acid reactive material and 7S collagen in plasma of patients with adult respiratory distress syndrome.
causal interaction
4
Acute Lung Injury
Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury.
causal interaction
4
Acute Lung Injury
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation.
causal interaction
3
Acute Lung Injury
Critical role of IL-17RA in immunopathology of influenza infection.
causal interaction
4
Acute Lung Injury
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
causal interaction
1
Acute Lung Injury
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
causal interaction
3
Acute Lung Injury
Heme Oxygenase-1 Mediates the Protective Effects of Ischemic Preconditioning on Mitigating Lung Injury Induced by Lower Limb Ischemia-Reperfusion in Rats.
causal interaction
1
Acute Lung Injury
Long-term Simvastatin Administration Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin.
causal interaction
4
Acute Lung Injury
Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
causal interaction
1
Acute Lung Injury
Cyanidin-3-O-?-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
causal interaction
2
Acute Lung Injury
High-altitude pulmonary edema can be prevented by heat shock protein 70-mediated hyperbaric oxygen preconditioning.
causal interaction
2
Acute Lung Injury
Formaldehyde inhalation during pregnancy abolishes the development of acute innate inflammation in offspring.
causal interaction
2
Acute Lung Injury
Absinthin attenuates LPS-induced ALI through MIP-1?-mediated inflammatory cell infiltration.
causal interaction
2
Acute Lung Injury
[Measurement of myeloperoxidase and thiobarbituric acid-reactive material in plasma and bronchoalveolar lavage in E. coli-induced acute lung injury]
diagnostic usage
3
Acute Lung Injury
The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate.
diagnostic usage
2
Acute Lung Injury
Clinical significance of measuring myeloperoxidase, thiobarbituric acid reactive material and 7S collagen in plasma of patients with adult respiratory distress syndrome.
diagnostic usage
4
Acute Lung Injury
Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
diagnostic usage
4
Acute Lung Injury
Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury.
diagnostic usage
2
Acute Lung Injury
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
diagnostic usage
4
Acute Lung Injury
Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway.
diagnostic usage
4
Acute Lung Injury
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
diagnostic usage
2
Acute Lung Injury
Long-term Simvastatin Administration Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin.
diagnostic usage
1
Acute Lung Injury
Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury in Rats: Role of the Protective Endothelium.
diagnostic usage
4
Acute Lung Injury
Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
diagnostic usage
3
Acute Lung Injury
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
diagnostic usage
4
Acute Lung Injury
High-altitude pulmonary edema can be prevented by heat shock protein 70-mediated hyperbaric oxygen preconditioning.
diagnostic usage
3
Acute Lung Injury
Absinthin attenuates LPS-induced ALI through MIP-1?-mediated inflammatory cell infiltration.
diagnostic usage
1
Acute Lung Injury
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
diagnostic usage
3
Acute Lung Injury
[Measurement of myeloperoxidase and thiobarbituric acid-reactive material in plasma and bronchoalveolar lavage in E. coli-induced acute lung injury]
therapeutic application
1
Acute Lung Injury
The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate.
therapeutic application
1
Acute Lung Injury
15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
therapeutic application
1
Acute Lung Injury
Smart imaging of acute lung injury: exploration of myeloperoxidase activity using in vivo endoscopic confocal fluorescence microscopy.
therapeutic application
1
Acute Lung Injury
Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.
therapeutic application
1
Acute Lung Injury
Myeloperoxidase-induced inactivation of alpha 1-antiprotease in hamsters.
therapeutic application
1
Acute Lung Injury
Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
therapeutic application
1
Acute Lung Injury
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation.
therapeutic application
1
Acute Lung Injury
Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.
therapeutic application
2
Acute Lung Injury
Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway.
therapeutic application
1
Acute Lung Injury
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
therapeutic application
4
Acute Lung Injury
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
therapeutic application
2
Acute Lung Injury
Heme Oxygenase-1 Mediates the Protective Effects of Ischemic Preconditioning on Mitigating Lung Injury Induced by Lower Limb Ischemia-Reperfusion in Rats.
therapeutic application
1
Acute Lung Injury
Long-term Simvastatin Administration Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin.
therapeutic application
2
Acute Lung Injury
Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury in Rats: Role of the Protective Endothelium.
therapeutic application
1
Acute Lung Injury
Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression.
therapeutic application
3
Acute Lung Injury
p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.
therapeutic application
1
Acute Lung Injury
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
therapeutic application
1
Acute Lung Injury
Cyanidin-3-O-?-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
therapeutic application
3
Acute Lung Injury
Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-?B-mediated inflammatory response.
therapeutic application
3
Acute Lung Injury
High-altitude pulmonary edema can be prevented by heat shock protein 70-mediated hyperbaric oxygen preconditioning.
therapeutic application
1
Acute Lung Injury
Formaldehyde inhalation during pregnancy abolishes the development of acute innate inflammation in offspring.
therapeutic application
1
Acute Lung Injury
Absinthin attenuates LPS-induced ALI through MIP-1?-mediated inflammatory cell infiltration.
therapeutic application
2
Acute Lung Injury
Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-?B-mediated inflammation.
therapeutic application
1
Acute Lung Injury
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-?B signaling in a murine model.
therapeutic application
3
Acute Lung Injury
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
therapeutic application
2
Acute Lung Injury
Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13?, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.
therapeutic application
2
Acute Lung Injury
?-Nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release.
therapeutic application
2
Acute Lung Injury
[Measurement of myeloperoxidase and thiobarbituric acid-reactive material in plasma and bronchoalveolar lavage in E. coli-induced acute lung injury]
ongoing research
2
Acute Lung Injury
The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate.
ongoing research
1
Acute Lung Injury
Smart imaging of acute lung injury: exploration of myeloperoxidase activity using in vivo endoscopic confocal fluorescence microscopy.
ongoing research
1
Acute Lung Injury
Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.
ongoing research
2
Acute Lung Injury
Clinical significance of measuring myeloperoxidase, thiobarbituric acid reactive material and 7S collagen in plasma of patients with adult respiratory distress syndrome.
ongoing research
3
Acute Lung Injury
Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.
ongoing research
2
Acute Lung Injury
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
ongoing research
2
Acute Lung Injury
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
ongoing research
2
Acute Lung Injury
Heme Oxygenase-1 Mediates the Protective Effects of Ischemic Preconditioning on Mitigating Lung Injury Induced by Lower Limb Ischemia-Reperfusion in Rats.
ongoing research
3
Acute Lung Injury
Long-term Simvastatin Administration Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin.
ongoing research
3
Acute Lung Injury
Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury in Rats: Role of the Protective Endothelium.
ongoing research
1
Acute Lung Injury
Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression.
ongoing research
4
Acute Lung Injury
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor.
ongoing research
2
Acute Lung Injury
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
ongoing research
4
Acute Lung Injury
High-altitude pulmonary edema can be prevented by heat shock protein 70-mediated hyperbaric oxygen preconditioning.
ongoing research
2
Acute Lung Injury
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-?B signaling in a murine model.
ongoing research
3
Acute Lung Injury
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
ongoing research
4
Acute Lung Injury
Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13?, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.
ongoing research
2
Acute Lung Injury
?-Nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release.
ongoing research
2
Acute Lung Injury
[Measurement of myeloperoxidase and thiobarbituric acid-reactive material in plasma and bronchoalveolar lavage in E. coli-induced acute lung injury]
unassigned
0
Acute Lung Injury
15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
unassigned
0
Acute Lung Injury
Smart imaging of acute lung injury: exploration of myeloperoxidase activity using in vivo endoscopic confocal fluorescence microscopy.
unassigned
0
Acute Lung Injury
Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
unassigned
0
Acute Lung Injury
Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.
unassigned
0
Acute Lung Injury
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
unassigned
0
Acute Lung Injury
Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway.
unassigned
0
Acute Lung Injury
Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury in Rats: Role of the Protective Endothelium.
unassigned
0
Acute Lung Injury
Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression.
unassigned
0
Acute Lung Injury
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor.
unassigned
0
Acute Lung Injury
p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.
unassigned
0
Acute Lung Injury
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
unassigned
0
Acute Lung Injury
Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-?B-mediated inflammatory response.
unassigned
0
Acute Lung Injury
Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-?B-mediated inflammation.
unassigned
0
Acute Lung Injury
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-?B signaling in a murine model.
unassigned
0
Acute Lung Injury
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
unassigned
0
Acute Lung Injury
Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13?, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.
unassigned
0
Acute Lung Injury
Oxygenation, inflammatory response and lung injury during one lung ventilation in rabbits using inspired oxygen fraction of 0.6 vs. 1.0.
unassigned
0
Acute Lung Injury
?-Nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release.
unassigned
0
Acute Lung Injury
Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.
unassigned
0
Acute Lung Injury
Myeloperoxidase-induced inactivation of alpha 1-antiprotease in hamsters.
unassigned
0
Acute Lung Injury
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation.
unassigned
0
Acute Lung Injury
Critical role of IL-17RA in immunopathology of influenza infection.
unassigned
0
Acute Lung Injury
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
unassigned
0
Acute Lung Injury
Heme Oxygenase-1 Mediates the Protective Effects of Ischemic Preconditioning on Mitigating Lung Injury Induced by Lower Limb Ischemia-Reperfusion in Rats.
unassigned
0
Acute Lung Injury
Cyanidin-3-O-?-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
unassigned
0
Acute Lung Injury
Formaldehyde inhalation during pregnancy abolishes the development of acute innate inflammation in offspring.
unassigned
0
Acute Lung Injury
Clinical significance of measuring myeloperoxidase, thiobarbituric acid reactive material and 7S collagen in plasma of patients with adult respiratory distress syndrome.
unassigned
0
Acute Lung Injury
Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury.
unassigned
0
Acute Lung Injury
Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
unassigned
0
Acute Lung Injury
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
unassigned
0
Acute Lung Injury
Absinthin attenuates LPS-induced ALI through MIP-1?-mediated inflammatory cell infiltration.
unassigned
0
Adenocarcinoma
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
causal interaction
4
Adenocarcinoma
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.
causal interaction
4
Adenocarcinoma
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
diagnostic usage
3
Adenocarcinoma
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
diagnostic usage
1
Adenocarcinoma
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.
diagnostic usage
4
Adenocarcinoma
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
therapeutic application
1
Adenocarcinoma
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
ongoing research
4
Adenocarcinoma
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
unassigned
0
Adenocarcinoma
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
unassigned
0
Adenocarcinoma
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
unassigned
0
Adenocarcinoma
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer.
unassigned
0
Agammaglobulinemia
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
causal interaction
4
Agammaglobulinemia
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
diagnostic usage
4
Agammaglobulinemia
[A spectrophotometric method of determining the myeloperoxidase activity in phagocytic cells]
unassigned
0
Aggressive Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
causal interaction
1
Aggressive Periodontitis
Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.
causal interaction
2
Aggressive Periodontitis
Myeloperoxidase staining in the diagnosis of aggressive periodontitis.
diagnostic usage
4
Aggressive Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
diagnostic usage
4
Aggressive Periodontitis
Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.
diagnostic usage
4
Aggressive Periodontitis
Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.
diagnostic usage
3
Aggressive Periodontitis
The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.
diagnostic usage
3
Aggressive Periodontitis
Amplified crevicular leukocyte activity in aggressive periodontal disease.
diagnostic usage
1
Aggressive Periodontitis
Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis.
therapeutic application
1
Aggressive Periodontitis
Genetic variation of myeloperoxidase gene contributes to aggressive periodontitis: a preliminary association study in Turkish population.
therapeutic application
1
Aggressive Periodontitis
Myeloperoxidase staining in the diagnosis of aggressive periodontitis.
therapeutic application
2
Aggressive Periodontitis
Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.
therapeutic application
3
Aggressive Periodontitis
Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.
therapeutic application
1
Aggressive Periodontitis
Amplified crevicular leukocyte activity in aggressive periodontal disease.
therapeutic application
1
Aggressive Periodontitis
Genetic variation of myeloperoxidase gene contributes to aggressive periodontitis: a preliminary association study in Turkish population.
ongoing research
2
Aggressive Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
ongoing research
4
Aggressive Periodontitis
Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.
ongoing research
3
Aggressive Periodontitis
The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.
ongoing research
4
Aggressive Periodontitis
Amplified crevicular leukocyte activity in aggressive periodontal disease.
ongoing research
1
Aggressive Periodontitis
Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis.
unassigned
0
Aggressive Periodontitis
Genetic variation of myeloperoxidase gene contributes to aggressive periodontitis: a preliminary association study in Turkish population.
unassigned
0
Aggressive Periodontitis
Myeloperoxidase staining in the diagnosis of aggressive periodontitis.
unassigned
0
Aggressive Periodontitis
Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.
unassigned
0
Aggressive Periodontitis
The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status.
unassigned
0
Aggressive Periodontitis
Amplified crevicular leukocyte activity in aggressive periodontal disease.
unassigned
0
Aggressive Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
unassigned
0
Aggressive Periodontitis
Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.
unassigned
0
Agranulocytosis
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
causal interaction
2
Agranulocytosis
Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
causal interaction
1
Agranulocytosis
Comparative metabolism and covalent binding of procainamide by human leukocytes.
causal interaction
4
Agranulocytosis
Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits.
causal interaction
4
Agranulocytosis
Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
causal interaction
2
Agranulocytosis
Drug-induced protein free radical formation is attenuated by unsaturated Fatty acids by scavenging drug-derived phenyl radical metabolites.
causal interaction
2
Agranulocytosis
Cocaine-Induced Vasculitis.
causal interaction
2
Agranulocytosis
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
diagnostic usage
2
Agranulocytosis
Involvement of Myeloperoxidase and NADPH Oxidase in the Covalent Binding of Amodiaquine and Clozapine to Neutrophils: Implications for Drug-Induced Agranulocytosis.
diagnostic usage
2
Agranulocytosis
Serum myeloperoxidase and lactoferrin in neutropenia.
diagnostic usage
4
Agranulocytosis
Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits.
diagnostic usage
1
Agranulocytosis
Peroxidase-catalysed oxidation of different dibenzazepine derivatives.
diagnostic usage
2
Agranulocytosis
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
therapeutic application
1
Agranulocytosis
Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
therapeutic application
4
Agranulocytosis
Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
therapeutic application
2
Agranulocytosis
Involvement of Myeloperoxidase and NADPH Oxidase in the Covalent Binding of Amodiaquine and Clozapine to Neutrophils: Implications for Drug-Induced Agranulocytosis.
therapeutic application
2
Agranulocytosis
Serum myeloperoxidase and lactoferrin in neutropenia.
therapeutic application
1
Agranulocytosis
Comparative metabolism and covalent binding of procainamide by human leukocytes.
therapeutic application
1
Agranulocytosis
Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
therapeutic application
1
Agranulocytosis
Drug-induced protein free radical formation is attenuated by unsaturated Fatty acids by scavenging drug-derived phenyl radical metabolites.
therapeutic application
2
Agranulocytosis
Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis.
ongoing research
1
Agranulocytosis
Serum myeloperoxidase and lactoferrin in neutropenia.
ongoing research
2
Agranulocytosis
Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis.
unassigned
0
Agranulocytosis
Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.
unassigned
0
Agranulocytosis
Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
unassigned
0
Agranulocytosis
Involvement of Myeloperoxidase and NADPH Oxidase in the Covalent Binding of Amodiaquine and Clozapine to Neutrophils: Implications for Drug-Induced Agranulocytosis.
unassigned
0
Agranulocytosis
Serum myeloperoxidase and lactoferrin in neutropenia.
unassigned
0
Agranulocytosis
Peroxidase-catalysed oxidation of different dibenzazepine derivatives.
unassigned
0
Agranulocytosis
Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.
unassigned
0
Agranulocytosis
Comparative metabolism and covalent binding of procainamide by human leukocytes.
unassigned
0
Agranulocytosis
Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
unassigned
0
Agranulocytosis
Drug-induced protein free radical formation is attenuated by unsaturated Fatty acids by scavenging drug-derived phenyl radical metabolites.
unassigned
0
Agranulocytosis
Cocaine-Induced Vasculitis.
unassigned
0
Agranulocytosis
Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits.
unassigned
0
Agranulocytosis
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
unassigned
0
Airway Obstruction
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
causal interaction
2
Airway Obstruction
Combined recombinant human activated protein C and ceftazidime prevent the onset of acute respiratory distress syndrome in severe sepsis.
causal interaction
4
Airway Obstruction
Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
diagnostic usage
3
Airway Obstruction
Combined recombinant human activated protein C and ceftazidime prevent the onset of acute respiratory distress syndrome in severe sepsis.
diagnostic usage
3
Airway Obstruction
Combined recombinant human activated protein C and ceftazidime prevent the onset of acute respiratory distress syndrome in severe sepsis.
therapeutic application
4
Airway Obstruction
Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
ongoing research
3
Airway Obstruction
Combined recombinant human activated protein C and ceftazidime prevent the onset of acute respiratory distress syndrome in severe sepsis.
ongoing research
4
Airway Obstruction
Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
unassigned
0
Airway Obstruction
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
unassigned
0
Alveolar Bone Loss
Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
causal interaction
2
Alveolar Bone Loss
Orabase formulation with cashew gum polysaccharide decreases inflammatory and bone loss hallmarks in experimental periodontitis.
causal interaction
2
Alveolar Bone Loss
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
diagnostic usage
4
Alveolar Bone Loss
Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
diagnostic usage
2
Alveolar Bone Loss
Effects of Polycan, a ?-glucan, on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats.
diagnostic usage
4
Alveolar Bone Loss
Effects of Melatonin on Oxidative Stress Index and Alveolar Bone Loss in Diabetic Rats With Periodontitis.
diagnostic usage
4
Alveolar Bone Loss
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats.
diagnostic usage
1
Alveolar Bone Loss
Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.
diagnostic usage
3
Alveolar Bone Loss
Periodontitis changes renal structures by oxidative stress and lipid peroxidation.
diagnostic usage
3
Alveolar Bone Loss
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
diagnostic usage
3
Alveolar Bone Loss
Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
therapeutic application
2
Alveolar Bone Loss
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
therapeutic application
2
Alveolar Bone Loss
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats.
therapeutic application
1
Alveolar Bone Loss
Periodontitis changes renal structures by oxidative stress and lipid peroxidation.
therapeutic application
1
Alveolar Bone Loss
Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
ongoing research
2
Alveolar Bone Loss
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
ongoing research
4
Alveolar Bone Loss
Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
ongoing research
3
Alveolar Bone Loss
Effects of Polycan, a ?-glucan, on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats.
ongoing research
4
Alveolar Bone Loss
Effects of Melatonin on Oxidative Stress Index and Alveolar Bone Loss in Diabetic Rats With Periodontitis.
ongoing research
3
Alveolar Bone Loss
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats.
ongoing research
4
Alveolar Bone Loss
Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.
ongoing research
3
Alveolar Bone Loss
Periodontitis changes renal structures by oxidative stress and lipid peroxidation.
ongoing research
1
Alveolar Bone Loss
Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats.
ongoing research
2
Alveolar Bone Loss
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
ongoing research
2
Alveolar Bone Loss
Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study.
unassigned
0
Alveolar Bone Loss
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
unassigned
0
Alveolar Bone Loss
Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
unassigned
0
Alveolar Bone Loss
Effects of Polycan, a ?-glucan, on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats.
unassigned
0
Alveolar Bone Loss
Effects of Melatonin on Oxidative Stress Index and Alveolar Bone Loss in Diabetic Rats With Periodontitis.
unassigned
0
Alveolar Bone Loss
The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone Loss in Rats.
unassigned
0
Alveolar Bone Loss
Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.
unassigned
0
Alveolar Bone Loss
Periodontitis changes renal structures by oxidative stress and lipid peroxidation.
unassigned
0
Alveolar Bone Loss
Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats.
unassigned
0
Alveolar Bone Loss
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
unassigned
0
Alveolar Bone Loss
Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
unassigned
0
Alveolar Bone Loss
Orabase formulation with cashew gum polysaccharide decreases inflammatory and bone loss hallmarks in experimental periodontitis.
unassigned
0
Alzheimer Disease
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
causal interaction
4
Alzheimer Disease
Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene.
causal interaction
2
Alzheimer Disease
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.
causal interaction
3
Alzheimer Disease
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.
causal interaction
4
Alzheimer Disease
No Genetic Association between the Myeloperoxidase Gene -463 Polymorphism and Estrogen Receptor-alpha Gene Polymorphisms and Japanese Sporadic Alzheimer's Disease.
causal interaction
3
Alzheimer Disease
Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.
causal interaction
4
Alzheimer Disease
Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain.
causal interaction
1
Alzheimer Disease
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
causal interaction
4
Alzheimer Disease
Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study.
causal interaction
4
Alzheimer Disease
Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
causal interaction
4
Alzheimer Disease
Observation of the multiple halogenation of peptides in the electrospray ionization source.
causal interaction
1
Alzheimer Disease
Myeloperoxidase: Bridging the gap in neurodegeneration.
causal interaction
2
Alzheimer Disease
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
diagnostic usage
4
Alzheimer Disease
Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.
diagnostic usage
4
Alzheimer Disease
Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain.
diagnostic usage
1
Alzheimer Disease
Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study.
diagnostic usage
1
Alzheimer Disease
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
therapeutic application
3
Alzheimer Disease
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.
therapeutic application
2
Alzheimer Disease
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
therapeutic application
1
Alzheimer Disease
Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
therapeutic application
1
Alzheimer Disease
Observation of the multiple halogenation of peptides in the electrospray ionization source.
therapeutic application
1
Alzheimer Disease
Myeloperoxidase: Bridging the gap in neurodegeneration.
therapeutic application
4
Alzheimer Disease
Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene.
ongoing research
4
Alzheimer Disease
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.
ongoing research
4
Alzheimer Disease
Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study.
ongoing research
3
Alzheimer Disease
No Genetic Association between the Myeloperoxidase Gene -463 Polymorphism and Estrogen Receptor-alpha Gene Polymorphisms and Japanese Sporadic Alzheimer's Disease.
ongoing research
2
Alzheimer Disease
Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.
ongoing research
3
Alzheimer Disease
Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study.
unassigned
0
Alzheimer Disease
Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.
unassigned
0
Alzheimer Disease
Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene.
unassigned
0
Alzheimer Disease
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.
unassigned
0
Alzheimer Disease
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.
unassigned
0
Alzheimer Disease
No Genetic Association between the Myeloperoxidase Gene -463 Polymorphism and Estrogen Receptor-alpha Gene Polymorphisms and Japanese Sporadic Alzheimer's Disease.
unassigned
0
Alzheimer Disease
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
unassigned
0
Alzheimer Disease
Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
unassigned
0
Alzheimer Disease
Observation of the multiple halogenation of peptides in the electrospray ionization source.
unassigned
0
Alzheimer Disease
Myeloperoxidase: Bridging the gap in neurodegeneration.
unassigned
0
Alzheimer Disease
Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.
unassigned
0
Alzheimer Disease
Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain.
unassigned
0
Alzheimer Disease
Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study.
unassigned
0
Alzheimer Disease
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
unassigned
0
Amyloidosis
[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]
diagnostic usage
4
Amyloidosis
[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]
ongoing research
2
Amyloidosis
[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]
unassigned
0
Amyotrophic Lateral Sclerosis
Myeloperoxidase: Bridging the gap in neurodegeneration.
causal interaction
2
Amyotrophic Lateral Sclerosis
Myeloperoxidase: Bridging the gap in neurodegeneration.
therapeutic application
4
Amyotrophic Lateral Sclerosis
Myeloperoxidase: Bridging the gap in neurodegeneration.
unassigned
0
Anemia
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
causal interaction
1
Anemia
Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
causal interaction
2
Anemia
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
causal interaction
1
Anemia
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
diagnostic usage
1
Anemia
Myeloperoxidase activity in polymorphonuclear neutrophils in nutritional anaemia.
diagnostic usage
1
Anemia
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
diagnostic usage
1
Anemia
Increased in vivo activation of neutrophils and complement in sickle cell disease.
diagnostic usage
4
Anemia
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
diagnostic usage
1
Anemia
Churg-strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.
diagnostic usage
3
Anemia
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
diagnostic usage
4
Anemia
Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
diagnostic usage
3
Anemia
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
diagnostic usage
4
Anemia
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
therapeutic application
1
Anemia
Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)).
therapeutic application
1
Anemia
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
therapeutic application
1
Anemia
Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.
therapeutic application
2
Anemia
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
ongoing research
2
Anemia
Increased in vivo activation of neutrophils and complement in sickle cell disease.
ongoing research
3
Anemia
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
ongoing research
2
Anemia
Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
ongoing research
2
Anemia
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
ongoing research
2
Anemia
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
unassigned
0
Anemia
Myeloperoxidase activity in polymorphonuclear neutrophils in nutritional anaemia.
unassigned
0
Anemia
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
unassigned
0
Anemia
Increased in vivo activation of neutrophils and complement in sickle cell disease.
unassigned
0
Anemia
Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)).
unassigned
0
Anemia
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
unassigned
0
Anemia
Churg-strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.
unassigned
0
Anemia
Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.
unassigned
0
Anemia
Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
unassigned
0
Anemia
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
unassigned
0
Anemia, Aplastic
Acquired myeloperoxidase deficiency of neutrophils in a patient with aplastic anemia (idiopathic marrow aplasia).
causal interaction
4
Anemia, Aplastic
Role of myeloperoxidase index in differentiation of megaloblastic and aplastic anemia.
diagnostic usage
4
Anemia, Aplastic
Role of myeloperoxidase index in differentiation of megaloblastic and aplastic anemia.
ongoing research
3
Anemia, Aplastic
Role of myeloperoxidase index in differentiation of megaloblastic and aplastic anemia.
unassigned
0
Anemia, Aplastic
Acquired myeloperoxidase deficiency of neutrophils in a patient with aplastic anemia (idiopathic marrow aplasia).
unassigned
0
Anemia, Hemolytic, Autoimmune
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
causal interaction
1
Anemia, Hemolytic, Autoimmune
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
diagnostic usage
4
Anemia, Hemolytic, Autoimmune
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
unassigned
0
Anemia, Iron-Deficiency
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
diagnostic usage
1
Anemia, Iron-Deficiency
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
ongoing research
2
Anemia, Iron-Deficiency
Myeloperoxidase activity of polymorphonuclear leukocytes in iron deficiency anemia and anemia of chronic disorders.
unassigned
0
Anemia, Megaloblastic
Neutrophil myeloperoxidase measurement uncovers masked megaloblastic anemia.
causal interaction
1
Anemia, Megaloblastic
Neutrophil myeloperoxidase measurement uncovers masked megaloblastic anemia.
therapeutic application
1
Anemia, Megaloblastic
Neutrophil myeloperoxidase measurement uncovers masked megaloblastic anemia.
ongoing research
2
Anemia, Megaloblastic
Neutrophil myeloperoxidase measurement uncovers masked megaloblastic anemia.
unassigned
0
Anemia, Refractory
Quantitative iodination of human blood polymorphonuclear leukocytes.
causal interaction
1
Anemia, Refractory
Quantitative iodination of human blood polymorphonuclear leukocytes.
diagnostic usage
3
Anemia, Refractory
Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
diagnostic usage
3
Anemia, Refractory
Quantitative iodination of human blood polymorphonuclear leukocytes.
therapeutic application
3
Anemia, Refractory
Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
therapeutic application
1
Anemia, Refractory
Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
ongoing research
2
Anemia, Refractory
Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
unassigned
0
Anemia, Refractory
Quantitative iodination of human blood polymorphonuclear leukocytes.
unassigned
0
Anemia, Sickle Cell
Inhibition of Myeloperoxidase Decreases Vascular Oxidative Stress and Increases Vasodilatation in Sickle Cell Disease Mice.
causal interaction
3
Anemia, Sickle Cell
Quantitative iodination of human blood polymorphonuclear leukocytes.
causal interaction
1
Anemia, Sickle Cell
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
causal interaction
1
Anemia, Sickle Cell
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
diagnostic usage
1
Anemia, Sickle Cell
Quantitative iodination of human blood polymorphonuclear leukocytes.
diagnostic usage
3
Anemia, Sickle Cell
Increased in vivo activation of neutrophils and complement in sickle cell disease.
diagnostic usage
4
Anemia, Sickle Cell
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
diagnostic usage
1
Anemia, Sickle Cell
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
diagnostic usage
4
Anemia, Sickle Cell
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
therapeutic application
1
Anemia, Sickle Cell
Inhibition of Myeloperoxidase Decreases Vascular Oxidative Stress and Increases Vasodilatation in Sickle Cell Disease Mice.
therapeutic application
2
Anemia, Sickle Cell
Quantitative iodination of human blood polymorphonuclear leukocytes.
therapeutic application
3
Anemia, Sickle Cell
Inhibition of Myeloperoxidase Decreases Vascular Oxidative Stress and Increases Vasodilatation in Sickle Cell Disease Mice.
ongoing research
4
Anemia, Sickle Cell
Increased in vivo activation of neutrophils and complement in sickle cell disease.
ongoing research
3
Anemia, Sickle Cell
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
ongoing research
2
Anemia, Sickle Cell
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
ongoing research
2
Anemia, Sickle Cell
Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia.
unassigned
0
Anemia, Sickle Cell
Increased in vivo activation of neutrophils and complement in sickle cell disease.
unassigned
0
Anemia, Sickle Cell
[Antineutrophil cytoplasmic antibodies in patients with sickle cell anemia]
unassigned
0
Anemia, Sickle Cell
Inhibition of Myeloperoxidase Decreases Vascular Oxidative Stress and Increases Vasodilatation in Sickle Cell Disease Mice.
unassigned
0
Anemia, Sickle Cell
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
unassigned
0
Anemia, Sickle Cell
Quantitative iodination of human blood polymorphonuclear leukocytes.
unassigned
0
Aneurysm
The inflammatory response to stent grafting of the thoracic aorta.
causal interaction
3
Aneurysm
Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease.
causal interaction
2
Aneurysm
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
causal interaction
4
Aneurysm
MR imaging of myeloperoxidase activity in a model of the inflamed aneurysm wall.
diagnostic usage
2
Aneurysm
The inflammatory response to stent grafting of the thoracic aorta.
diagnostic usage
3
Aneurysm
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
diagnostic usage
1
Aneurysm
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
diagnostic usage
4
Aneurysm
MR imaging of myeloperoxidase activity in a model of the inflamed aneurysm wall.
therapeutic application
3
Aneurysm
Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease.
therapeutic application
3
Aneurysm
Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.
therapeutic application
1
Aneurysm
Myeloperoxidase in Human Intracranial Aneurysms: Preliminary Evidence.
therapeutic application
1
Aneurysm
MR imaging of myeloperoxidase activity in a model of the inflamed aneurysm wall.
ongoing research
2
Aneurysm
Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.
ongoing research
3
Aneurysm
Myeloperoxidase in Human Intracranial Aneurysms: Preliminary Evidence.
ongoing research
4
Aneurysm
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
ongoing research
2
Aneurysm
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
ongoing research
4
Aneurysm
MR imaging of myeloperoxidase activity in a model of the inflamed aneurysm wall.
unassigned
0
Aneurysm
Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.
unassigned
0
Aneurysm
Myeloperoxidase in Human Intracranial Aneurysms: Preliminary Evidence.
unassigned
0
Aneurysm
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
unassigned
0
Aneurysm
Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease.
unassigned
0
Aneurysm
The inflammatory response to stent grafting of the thoracic aorta.
unassigned
0
Aneurysm
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
unassigned
0
Aneurysm, Ruptured
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
diagnostic usage
4
Aneurysm, Ruptured
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
ongoing research
4
Aneurysm, Ruptured
The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms.
unassigned
0
Angina Pectoris
KORVITIN REDUCES THE HIGH MAINTENANCE OF MYELOPEROXIDASE IN PLASMA OF BLOOD OF PATIENTS WITH THE ACUTE INFARCT OF MYOCARDIUM.
diagnostic usage
3
Angina Pectoris
KORVITIN REDUCES THE HIGH MAINTENANCE OF MYELOPEROXIDASE IN PLASMA OF BLOOD OF PATIENTS WITH THE ACUTE INFARCT OF MYOCARDIUM.
ongoing research
1
Angina Pectoris
KORVITIN REDUCES THE HIGH MAINTENANCE OF MYELOPEROXIDASE IN PLASMA OF BLOOD OF PATIENTS WITH THE ACUTE INFARCT OF MYOCARDIUM.
unassigned
0
Angina, Stable
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
causal interaction
4
Angina, Stable
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
causal interaction
4
Angina, Stable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
causal interaction
4
Angina, Stable
Widespread coronary inflammation in unstable angina.
causal interaction
4
Angina, Stable
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
causal interaction
3
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
causal interaction
3
Angina, Stable
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
diagnostic usage
4
Angina, Stable
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
diagnostic usage
4
Angina, Stable
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
diagnostic usage
4
Angina, Stable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
diagnostic usage
4
Angina, Stable
Widespread coronary inflammation in unstable angina.
diagnostic usage
1
Angina, Stable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
diagnostic usage
4
Angina, Stable
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
diagnostic usage
3
Angina, Stable
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
diagnostic usage
1
Angina, Stable
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
diagnostic usage
1
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
diagnostic usage
4
Angina, Stable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
therapeutic application
3
Angina, Stable
Widespread coronary inflammation in unstable angina.
therapeutic application
2
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
therapeutic application
4
Angina, Stable
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
ongoing research
2
Angina, Stable
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
ongoing research
1
Angina, Stable
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
ongoing research
1
Angina, Stable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
ongoing research
3
Angina, Stable
Widespread coronary inflammation in unstable angina.
ongoing research
3
Angina, Stable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
ongoing research
2
Angina, Stable
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
ongoing research
3
Angina, Stable
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
ongoing research
2
Angina, Stable
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
unassigned
0
Angina, Stable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
unassigned
0
Angina, Stable
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.
unassigned
0
Angina, Stable
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
unassigned
0
Angina, Stable
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
unassigned
0
Angina, Stable
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
unassigned
0
Angina, Stable
[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
unassigned
0
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
unassigned
0
Angina, Unstable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
causal interaction
4
Angina, Unstable
Widespread coronary inflammation in unstable angina.
causal interaction
4
Angina, Unstable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
diagnostic usage
4
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
diagnostic usage
4
Angina, Unstable
Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
diagnostic usage
3
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
diagnostic usage
3
Angina, Unstable
Widespread coronary inflammation in unstable angina.
diagnostic usage
1
Angina, Unstable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
diagnostic usage
4
Angina, Unstable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
therapeutic application
3
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
therapeutic application
1
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
therapeutic application
3
Angina, Unstable
Widespread coronary inflammation in unstable angina.
therapeutic application
2
Angina, Unstable
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.
ongoing research
3
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
ongoing research
4
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
ongoing research
4
Angina, Unstable
Widespread coronary inflammation in unstable angina.
ongoing research
3
Angina, Unstable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
ongoing research
2
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
unassigned
0
Angina, Unstable
Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
unassigned
0
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
unassigned
0
Angina, Unstable
Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
unassigned
0
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome with myeloperoxidase specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) during chronic interstitial pneumonia]
causal interaction
3
Anti-Glomerular Basement Membrane Disease
AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.
causal interaction
2
Anti-Glomerular Basement Membrane Disease
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature.
causal interaction
1
Anti-Glomerular Basement Membrane Disease
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.
diagnostic usage
3
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome. Myeloperoxidase antibodies as a valuable serological marker in vasculitis]
diagnostic usage
4
Anti-Glomerular Basement Membrane Disease
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
diagnostic usage
2
Anti-Glomerular Basement Membrane Disease
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
diagnostic usage
4
Anti-Glomerular Basement Membrane Disease
Anti-GBM disease and ANCA during dengue infection.
diagnostic usage
3
Anti-Glomerular Basement Membrane Disease
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature.
diagnostic usage
2
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome. Myeloperoxidase antibodies as a valuable serological marker in vasculitis]
therapeutic application
1
Anti-Glomerular Basement Membrane Disease
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
therapeutic application
2
Anti-Glomerular Basement Membrane Disease
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
therapeutic application
1
Anti-Glomerular Basement Membrane Disease
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature.
therapeutic application
1
Anti-Glomerular Basement Membrane Disease
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.
ongoing research
1
Anti-Glomerular Basement Membrane Disease
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
ongoing research
1
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome with myeloperoxidase specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) during chronic interstitial pneumonia]
ongoing research
1
Anti-Glomerular Basement Membrane Disease
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
ongoing research
2
Anti-Glomerular Basement Membrane Disease
Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture's syndrome: a case report and review of the literature.
ongoing research
3
Anti-Glomerular Basement Membrane Disease
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.
unassigned
0
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome. Myeloperoxidase antibodies as a valuable serological marker in vasculitis]
unassigned
0
Anti-Glomerular Basement Membrane Disease
Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease.
unassigned
0
Anti-Glomerular Basement Membrane Disease
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
unassigned
0
Anti-Glomerular Basement Membrane Disease
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
unassigned
0
Anti-Glomerular Basement Membrane Disease
Anti-GBM disease and ANCA during dengue infection.
unassigned
0
Anti-Glomerular Basement Membrane Disease
[A case of Goodpasture's syndrome with myeloperoxidase specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) during chronic interstitial pneumonia]
unassigned
0
Anti-Glomerular Basement Membrane Disease
AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?
causal interaction
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
The role of myeloperoxidase in the pathogenesis of systemic vasculitis.
causal interaction
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
causal interaction
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
causal interaction
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
causal interaction
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis.
causal interaction
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
causal interaction
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
causal interaction
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.
causal interaction
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Deglycosylation influences the oxidation activity and antigenicity of myeloperoxidase.
causal interaction
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
causal interaction
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
diagnostic usage
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
diagnostic usage
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
diagnostic usage
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease.
diagnostic usage
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
diagnostic usage
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
diagnostic usage
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
diagnostic usage
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Endothelial tissue factor stimulation by proteinase 3 and elastase.
therapeutic application
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis.
therapeutic application
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis.
therapeutic application
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies.
therapeutic application
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
therapeutic application
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
therapeutic application
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
ongoing research
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
ongoing research
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
The role of myeloperoxidase in the pathogenesis of systemic vasculitis.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
ongoing research
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
ongoing research
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis.
ongoing research
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease.
ongoing research
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
ongoing research
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
ongoing research
3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
ongoing research
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
ongoing research
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
ongoing research
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Endothelial tissue factor stimulation by proteinase 3 and elastase.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
[Microscopic polyangiitis]
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Thymic Deletion and Regulatory T Cells Prevent Antimyeloperoxidase GN.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Direct and indirect pathogenic roles of autoantibodies in systemic autoimmune diseases.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
The role of myeloperoxidase in the pathogenesis of systemic vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Deglycosylation influences the oxidation activity and antigenicity of myeloperoxidase.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
unassigned
0
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?
unassigned
0
Antiphospholipid Syndrome
Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
therapeutic application
3
Antiphospholipid Syndrome
Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
unassigned
0
Anuria
An unusual presentation of antineutrophil cytoplasmic antibody-associated vasculitis: discrepancy between histopathology and clinical presentation.
therapeutic application
1
Anuria
An unusual presentation of antineutrophil cytoplasmic antibody-associated vasculitis: discrepancy between histopathology and clinical presentation.
ongoing research
1
Anuria
An unusual presentation of antineutrophil cytoplasmic antibody-associated vasculitis: discrepancy between histopathology and clinical presentation.
unassigned
0
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
causal interaction
4
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
diagnostic usage
4
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
therapeutic application
1
Aortic Aneurysm, Abdominal
Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
therapeutic application
1
Aortic Aneurysm, Abdominal
Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
ongoing research
1
Aortic Aneurysm, Abdominal
Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
unassigned
0
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
unassigned
0
Aortic Valve Stenosis
Myeloperoxidase and progression of aortic valve stenosis in patients undergoing hemodialysis.
causal interaction
2
Aortic Valve Stenosis
Aortic valve replacement in a patient with MPO-ANCA-positive Goodpasture disease.
causal interaction
2
Aortic Valve Stenosis
Myeloperoxidase and progression of aortic valve stenosis in patients undergoing hemodialysis.
diagnostic usage
4
Aortic Valve Stenosis
Myeloperoxidase and progression of aortic valve stenosis in patients undergoing hemodialysis.
therapeutic application
1
Aortic Valve Stenosis
Aortic valve replacement in a patient with MPO-ANCA-positive Goodpasture disease.
unassigned
0
Aortic Valve Stenosis
Myeloperoxidase and progression of aortic valve stenosis in patients undergoing hemodialysis.
unassigned
0
Aortitis
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
diagnostic usage
3
Aortitis
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
therapeutic application
1
Aortitis
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
unassigned
0
Apnea
Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils.
causal interaction
3
Apnea
Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils.
therapeutic application
2
Apnea
Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils.
unassigned
0
Appendicitis
The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children.
causal interaction
1
Appendicitis
The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children.
diagnostic usage
4
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
diagnostic usage
3
Appendicitis
Composition of the cellular infiltrate in patients with simple and complex appendicitis.
diagnostic usage
3
Appendicitis
The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children.
therapeutic application
1
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
therapeutic application
1
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
ongoing research
1
Appendicitis
Composition of the cellular infiltrate in patients with simple and complex appendicitis.
ongoing research
1
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
unassigned
0
Appendicitis
Composition of the cellular infiltrate in patients with simple and complex appendicitis.
unassigned
0
Appendicitis
The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children.
unassigned
0
Arteriosclerosis
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
causal interaction
1
Arteriosclerosis
[Myeloperoxidase activity in patients with complicated arteriosclerosis and in their relatives]
causal interaction
3
Arteriosclerosis
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
diagnostic usage
4
Arteriosclerosis
[Myeloperoxidase activity in patients with complicated arteriosclerosis and in their relatives]
diagnostic usage
3
Arteriosclerosis
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
therapeutic application
2
Arteriosclerosis
[Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis]
ongoing research
3
Arteriosclerosis
[Myeloperoxidase activity in patients with complicated arteriosclerosis and in their relatives]
ongoing research
1
Arteriosclerosis
[Myeloperoxidase activity in patients with complicated arteriosclerosis and in their relatives]
unassigned
0
Arteriovenous Fistula
Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas.
diagnostic usage
4
Arteriovenous Fistula
Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas.
therapeutic application
1
Arteriovenous Fistula
Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas.
unassigned
0
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
causal interaction
3
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
diagnostic usage
3
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
unassigned
0
Arteritis
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
causal interaction
4
Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
diagnostic usage
4
Arteritis
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
diagnostic usage
3
Arteritis
A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy.
diagnostic usage
2
Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
therapeutic application
1
Arteritis
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
therapeutic application
2
Arteritis
A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy.
therapeutic application
2
Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
ongoing research
3
Arteritis
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
unassigned
0
Arteritis
A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy.
unassigned
0
Arteritis
Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.
unassigned
0
Arthralgia
Cocaine-Induced Vasculitis.
causal interaction
2
Arthralgia
Cocaine-Induced Vasculitis.
unassigned
0
Arthritis
Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis.
causal interaction
1
Arthritis
Is Taurolidine a candidate for treatment of rheumatoid arthritis?
causal interaction
1
Arthritis
Melatonin is a potent inhibitor for myeloperoxidase.
causal interaction
2
Arthritis
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.
causal interaction
2
Arthritis
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
causal interaction
3
Arthritis
Scientific validation of Anti-arthritic effect of Kashayams - a polyherbal formulation in collagen induced arthritic rats.
causal interaction
2
Arthritis
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
diagnostic usage
1
Arthritis
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
diagnostic usage
4
Arthritis
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
diagnostic usage
2
Arthritis
Is Taurolidine a candidate for treatment of rheumatoid arthritis?
diagnostic usage
4
Arthritis
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
diagnostic usage
2
Arthritis
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
diagnostic usage
1
Arthritis
The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats.
diagnostic usage
4
Arthritis
Scientific validation of Anti-arthritic effect of Kashayams - a polyherbal formulation in collagen induced arthritic rats.
diagnostic usage
3
Arthritis
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
therapeutic application
1
Arthritis
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
therapeutic application
1
Arthritis
Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model.
therapeutic application
1
Arthritis
Melatonin is a potent inhibitor for myeloperoxidase.
therapeutic application
1
Arthritis
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
therapeutic application
1
Arthritis
Combination of carvacrol with methotrexate suppresses Complete Freund's Adjuvant induced synovial inflammation with reduced hepatotoxicity in rats.
therapeutic application
1
Arthritis
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.
therapeutic application
2
Arthritis
Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.
therapeutic application
4
Arthritis
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
therapeutic application
1
Arthritis
The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats.
therapeutic application
1
Arthritis
Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase.
ongoing research
2
Arthritis
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
ongoing research
4
Arthritis
Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis.
ongoing research
2
Arthritis
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
ongoing research
4
Arthritis
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
ongoing research
1
Arthritis
Immunomodulatory and anti-inflammatory effects of Semecarpus anacardium LINN. Nut milk extract in experimental inflammatory conditions.
ongoing research
3
Arthritis
Is Taurolidine a candidate for treatment of rheumatoid arthritis?
ongoing research
2
Arthritis
Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model.
ongoing research
2
Arthritis
Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis.
ongoing research
1
Arthritis
Antinociceptive and antidepressant-like effects of the crude extract of Vitex megapotamica in rats.
ongoing research
1
Arthritis
The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats.
ongoing research
1
Arthritis
Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase.
unassigned
0
Arthritis
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
unassigned
0
Arthritis
Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
unassigned
0
Arthritis
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
unassigned
0
Arthritis
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
unassigned
0
Arthritis
Kupffer-cell depletion attenuates colonic and extracolonic granulomatous inflammation in chronic colitis.
unassigned
0
Arthritis
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
unassigned
0
Arthritis
Immunomodulatory and anti-inflammatory effects of Semecarpus anacardium LINN. Nut milk extract in experimental inflammatory conditions.
unassigned
0
Arthritis
Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model.
unassigned
0
Arthritis
Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis.
unassigned
0
Arthritis
Combination of carvacrol with methotrexate suppresses Complete Freund's Adjuvant induced synovial inflammation with reduced hepatotoxicity in rats.
unassigned
0
Arthritis
Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.
unassigned
0
Arthritis
Antinociceptive and antidepressant-like effects of the crude extract of Vitex megapotamica in rats.
unassigned
0
Arthritis
The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats.
unassigned
0
Arthritis
Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis.
unassigned
0
Arthritis
Melatonin is a potent inhibitor for myeloperoxidase.
unassigned
0
Arthritis
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.
unassigned
0
Arthritis
Is Taurolidine a candidate for treatment of rheumatoid arthritis?
unassigned
0
Arthritis
Scientific validation of Anti-arthritic effect of Kashayams - a polyherbal formulation in collagen induced arthritic rats.
unassigned
0
Arthritis, Experimental
Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil.
therapeutic application
3
Arthritis, Experimental
Clitoria ternatea flower petals: Effect on TNFR1 neutralization via downregulation of synovial matrix metalloproteases.
therapeutic application
4
Arthritis, Experimental
Bis(phenylimidazoselenazolyl) diselenide elicits antinociceptive effect by modulating myeloperoxidase activity, NOx and NFkB levels in the collagen-induced arthritis mouse model.
ongoing research
1
Arthritis, Experimental
Clitoria ternatea flower petals: Effect on TNFR1 neutralization via downregulation of synovial matrix metalloproteases.
ongoing research
2
Arthritis, Experimental
Bis(phenylimidazoselenazolyl) diselenide elicits antinociceptive effect by modulating myeloperoxidase activity, NOx and NFkB levels in the collagen-induced arthritis mouse model.
unassigned
0
Arthritis, Experimental
Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil.
unassigned
0
Arthritis, Experimental
Clitoria ternatea flower petals: Effect on TNFR1 neutralization via downregulation of synovial matrix metalloproteases.
unassigned
0
Arthritis, Juvenile
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
diagnostic usage
1
Arthritis, Juvenile
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
diagnostic usage
2
Arthritis, Juvenile
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
therapeutic application
1
Arthritis, Juvenile
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
therapeutic application
1
Arthritis, Juvenile
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
ongoing research
4
Arthritis, Juvenile
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
ongoing research
1
Arthritis, Juvenile
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
unassigned
0
Arthritis, Juvenile
Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
unassigned
0
Arthritis, Juvenile
Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
unassigned
0
Arthritis, Psoriatic
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.
diagnostic usage
1
Arthritis, Psoriatic
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.
therapeutic application
2
Arthritis, Psoriatic
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.
unassigned
0
Arthritis, Reactive
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
diagnostic usage
4
Arthritis, Reactive
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
ongoing research
4
Arthritis, Reactive
Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.
unassigned
0
Arthritis, Rheumatoid
Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.
causal interaction
4
Arthritis, Rheumatoid
Myeloperoxidase deficiency in a patient with rheumatoid arthritis: oxygenation and radical activity by phagocytic cells.
causal interaction
4
Arthritis, Rheumatoid
[Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases]
causal interaction
1
Arthritis, Rheumatoid
Increased myeloperoxidase plasma levels in rheumatoid arthritis.
causal interaction
4
Arthritis, Rheumatoid
Myeloperoxidase and oxidative stress in rheumatoid arthritis.
causal interaction
2
Arthritis, Rheumatoid
High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
causal interaction
4
Arthritis, Rheumatoid
Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis.
causal interaction
4
Arthritis, Rheumatoid